UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000049237
Receipt number R000056077
Scientific Title Deep Learning-Based Prediction of Cardiovascular Outcomes using Optical Coherence Tomography in Patients with Acute Coronary Syndrome
Date of disclosure of the study information 2023/01/01
Last modified on 2022/10/17 12:50:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Deep Learning-Based Prediction of Cardiovascular Outcomes using Optical Coherence Tomography in Patients with Acute Coronary Syndrome

Acronym

Deep Learning-Based Prediction of Cardiovascular Outcomes using Optical Coherence Tomography in Patients with Acute Coronary Syndrome

Scientific Title

Deep Learning-Based Prediction of Cardiovascular Outcomes using Optical Coherence Tomography in Patients with Acute Coronary Syndrome

Scientific Title:Acronym

Deep Learning-Based Prediction of Cardiovascular Outcomes using Optical Coherence Tomography in Patients with Acute Coronary Syndrome

Region

Japan


Condition

Condition

acute coronary syndrome

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To create a prognosis prediction model directly from post-percutaneous coronary syndrome (PCI) optical coherence tomography (OCT) images of patients with acute coronary syndrome using a deep learning model.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Target vessel failure

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

(1) Patients enrolled in a previous study, "A retrospective multicenter registry of the morphological characteristics of responsible plaques in patients with acute coronary syndromes from the perspective of age and gender" (UMIN000038442).
(ii) Patients who received OCT examination after PCI to ACS

Key exclusion criteria

(1) Patients who have asked not to participate in this study based on publicly available information.
(2) Patients who had ACS due to in-stent restenosis or occlusion
(3) Patients with graft vessels
(4) Patients with lesions in the left main trunk or the ostium of the right coronary artery
(5) Patients who did not undergo stenting at PCI
(6) Patients with Thrombolysis in myocardial infarction trial (TIMI) flow grade 2 or less at the final coronary angiogram

Target sample size

360


Research contact person

Name of lead principal investigator

1st name Hiromasa
Middle name
Last name Otake

Organization

Kobe University Hospital

Division name

Division of Cardiovascular Medicine

Zip code

6500017

Address

7-5-2 Kusunoki-cho, Chuo-ku, Kobe

TEL

0783825846

Email

hotake@med.kobe-u.ac.jp


Public contact

Name of contact person

1st name Tomoyo
Middle name
Last name Hamana

Organization

Kobe University Hospital

Division name

Division of Cardiovascular Medicine

Zip code

6500017

Address

7-5-2 Kusunoki-cho, Chuo-ku, Kobe

TEL

0783825846

Homepage URL


Email

tomohamachi@yahoo.co.jp


Sponsor or person

Institute

Kobe University, department of cardiology

Institute

Department

Personal name



Funding Source

Organization

Kobe University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kobe university hospital clinical and translational research center

Address

7-5-2 Kusunoki-cho, Chuo-ku, Kobe

Tel

0783825846

Email

kansatsu@med.kobe-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2022 Year 12 Month 31 Day

Date of IRB


Anticipated trial start date

2023 Year 01 Month 01 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2022 Year 10 Month 17 Day

Last modified on

2022 Year 10 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056077


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name